undamentalytics Newsletter

Talphera, Inc. revenue

Talphera, Inc.'s revenue was $28,000 in fiscal 2025. Since fiscal 2011 ($1.1m) it has grown at a compound -22.9% a year. Over the last twelve months it was $1,000.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Talphera, Inc.: revenue history, annual
Fiscal year2011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue1230519178225301000
Growth on the year before—+123.3%+>999%−82.3%+269.2%−9.9%−53.9%−73.1%+6.4%+136.6%−48.0%−100.0%—−100.0%——
Gross profit—————5−3−2−5−1−1−3————
Gross margin—————29.0%−33.3%−84.8%—−11.4%−33.2%—————

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Pharmaceuticals: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Talphera, Inc. $1,000 -96.3% -92.4%
PRF Technologies Ltd. $17,000 — —
Akanda Corp. $258,075 -69.2% —
Scienture Holdings, Inc. $821,315 540.6% -58.5%
60 Degrees Pharmaceuticals, Inc. $1.1m 73.2% 74.9%
China SXT Pharmaceuticals, Inc. $1.1m -34.6% —

Compare with peers

Head to head: PRFX vs TLPHAKAN vs TLPHSCNX vs TLPH

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Talphera, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Talphera, Inc.